MedPath

The effect of pre-operative Ramipril treatment on vascular inflammation in the abdominal aneurysm

Conditions
An aneurysm of the abdominal aorta
MedDRA version: 8.1Level: LLTClassification code 10002882Term: Aortic aneurysm
Registration Number
EUCTR2006-006105-86-NL
Lead Sponsor
MC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Elective aneurysm repair operation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Hypotension
Renal artery stenosis

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To test whether Ramipril, via its presumed effects on NFkB activation, reduces vascular inflammation in the abdominal aneurysm.;Secondary Objective: Te test whether Ramipril reduces protease activity in the abdominal aneurysm;Primary end point(s): NFkB activation in the aortic wall<br>IL-6 and 8 expression in the aortic wall
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath